Adaptive Anti-MICA Antigen Binding Fragments for Extreme Environments
Legal Citation
Summary of the Inventive Concept
This inventive concept adapts anti-MICA antigen binding fragments for specific, narrow markets and unique operational environments, enhancing their effectiveness in extreme weather conditions, high-security settings, and disaster relief scenarios.
Background and Problem Solved
The original patent disclosed anti-MICA antigen binding fragments, but these fragments have limitations in certain environments. This new inventive concept addresses these limitations by providing specialized variations and niche solutions, enabling the effective detection and treatment of MICA-expressing cancer cells in extreme weather conditions, high-security environments, and disaster relief scenarios.
Detailed Description of the Inventive Concept
The inventive concept comprises a system for detecting MICA-expressing cancer cells in extreme weather conditions, featuring a polynucleotide encoding an anti-MICA chimeric antigen receptor (CAR) and a weather-resistant detector unit. Additionally, the concept includes a method for treating MICA-expressing cancer cells in a high-security environment, utilizing an anti-MICA CAR-expressing cell and a secure communication network. Furthermore, a disaster relief kit is proposed, comprising a portable container housing an anti-MICA CAR-expressing cell, a portable detector unit, and a communication device for contacting emergency services.
Novelty and Inventive Step
The new claims introduce novel and non-obvious elements, such as weather-resistant detector units, secure communication networks, and portable disaster relief kits, which significantly enhance the functionality and applicability of the original anti-MICA antigen binding fragments.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include adapting the anti-MICA CAR-expressing cells for use in space exploration, developing miniaturized detector units for wearable devices, or integrating the secure communication network with existing emergency response systems.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the fields of cancer treatment, disaster relief, and high-security medical services, with potential applications in extreme weather conditions, such as search and rescue operations, and in high-security environments, such as military medical facilities.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Molecular biology, immunotherapy, and chimeric antigen receptor (CAR) technology, with expertise in cancer cell detection and targeted cellular therapies
Person of Ordinary Skill (PHOSITA) Profile
A researcher with advanced degrees in molecular biology or bioengineering, experienced in CAR design, antigen targeting, and cellular therapeutic strategies, familiar with NKG2D receptor systems and cancer immunotherapies
Obviousness Rationale
A person of ordinary skill would recognize that extending the anti-MICA CAR technology to specific environmental and operational contexts represents a predictable application of known immunotherapeutic principles. The fundamental CAR design remains consistent with the source patent, while the proposed variations merely adapt the existing technology to novel deployment scenarios. These adaptations leverage standard engineering approaches to expand the utility of the original cellular therapeutic concept.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,571 |
|---|---|
| Title | Anti-mica antigen binding fragments, fusion molecules, cells which express and methods of using |
| Assignee(s) | The Trustees of Dartmouth College |